Julia Post

Julia Post

Julia Post‘s practice consists primarily of representing clients in Hatch-Waxman patent litigation and providing advice to clients on a variety of federal and state regulatory matters relating to drugs and devices.

Subscribe to all posts by Julia Post

Oregon HB 4005: New Reporting Requirements for Drug Manufacturers, Health Insurers

On Tuesday, March 13, 2018, Oregon Governor Kate Brown signed into law House Bill 4005 (HB 4005), which imposes substantial new state reporting requirements on pharmaceutical manufacturers regarding drug pricing, including details on manufacturer-sponsored patient assistance programs. HB 4005 also imposes new reporting requirements on health insurers and establishes a temporary task force charged with … Continue Reading
LexBlog